Napsin A and Thyroid Transcription Factor-1-Positive Cerebellar Tumor with Epidermal Growth Factor Receptor Mutation

Publisher： Karger

E-ISSN： 1662-6575|4|3|564-568

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.3, 2011-12, pp. : 564-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-06 ,pp. : 393-400

Karger

Access to resources Recommend Favorite

Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 964-969

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 11, 2015-11 ,pp. : 633-643

John Wiley & Sons Inc

Access to resources Recommend Favorite